Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease

Author： Rinaldi P. Polidori M.C. Metastasio A. Mariani E. Mattioli P. Cherubini A. Catani M. Cecchetti R. Senin U. Mecocci P.

Publisher： Elsevier

ISSN： 0197-4580

Source： Neurobiology of Aging, Vol.24, Iss.7, 2003-11, pp. : 915-919

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memory-related EEG power and coherence reductions in mild Alzheimer's disease

By Hogan M.J. Swanwick G.R.J. Kaiser J. Rowan M. Lawlor B.

International Journal of Psychophysiology, Vol. 49, Iss. 2, 2003-08 ,pp. : 147-163

Elsevier

Access to resources Recommend Favorite

Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease

By Bartzokis G.

Neurobiology of Aging, Vol. 25, Iss. 1, 2004-01 ,pp. : 5-18

Elsevier

Access to resources Recommend Favorite

Estrogen and Basal Forebrain Cholinergic Neurons: Implications for Brain Aging and Alzheimer's Disease-Related Cognitive Decline

By Gibbs R.B. Aggarwal P.

Hormones and Behavior, Vol. 34, Iss. 2, 1998-10 ,pp. : 98-111

Academic Press

Access to resources Recommend Favorite

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease

By Selley M.L.

Neurobiology of Aging, Vol. 24, Iss. 7, 2003-11 ,pp. : 903-907

Elsevier

Access to resources Recommend Favorite

Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype

By Craft S. Asthana S. Cook D.G. Baker L.D. Cherrier M. Purganan K. Wait C. Petrova A. Latendresse S. Watson G.S. Newcomer J.W. Schellenberg G.D. Krohn A.J.

Psychoneuroendocrinology, Vol. 28, Iss. 6, 2003-08 ,pp. : 809-822

Elsevier

Access to resources Recommend Favorite